Sign Up to like & get
recommendations!
1
Published in 2018 at "International journal of biological macromolecules"
DOI: 10.1016/j.ijbiomac.2018.07.042
Abstract: Experimental studies have demonstrated that L858R mutation in the EGF receptor (EGFR) confers tumor sensitivity whereas T790M and L858R/T790M mutations cause resistance to tyrosine kinase inhibitors in patients with non-small cell lung cancer. Theoretical studies…
read more here.
Keywords:
egfr;
l858r;
analysis;
t790m l858r ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Molecules"
DOI: 10.3390/molecules25122914
Abstract: Rociletinib (CO-1686), a 2,4-diaminopyrimidine derivative, is a highly potent tyrosine kinase inhibitor (TKI) that acts on epidermal growth factor receptor (EGFR) with L858R/T790M mutations. We supposed radioiodinated CO-1686 would function as a useful tool for…
read more here.
Keywords:
egfr l858r;
l858r;
h1975;
l858r t790m ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Journal of Pathology and Translational Medicine"
DOI: 10.4132/jptm.2018.07.29
Abstract: Background MicroRNAs (miRNAs) are short, non-coding RNAs that mediate post-transcriptional gene regulation. They are commonly deregulated in human malignancies, including non-small cell lung cancer (NSCLC). The aim of this study is to investigate miRNA expression…
read more here.
Keywords:
egfr t790m;
l858r;
mir;
group ... See more keywords